LIMN · Liminatus Pharma, Inc.
$4.23
-0.17 (-3.86%)
At close · Aug 28
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“management has concluded that there is substantial doubt about its ability to continue as a going concern for one year after the date that the accompanying unaudited condensed consolidated financial statements are issued.”View the 10-Q filed Aug 14, 2026
Market Cap
$5.91M
Shares
1.34M
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-07-31 | 11,521 | $0.10 | $1,152 |
| 2026-07-30 | 18,106 | $0.11 | $1,992 |
| 2026-07-29 | 24,508 | $0.10 | $2,451 |
| 2026-07-28 | 2,593 | $0.10 | $259 |
| 2026-07-27 | 191 | $0.11 | $21 |
| 2026-07-24 | 12,765 | $0.12 | $1,532 |
| 2026-07-23 | 121,969 | $0.12 | $14,636 |
| 2026-07-22 | 58,065 | $0.12 | $6,968 |
| 2026-07-21 | 598,410 | $0.11 | $65,825 |
| 2026-07-20 | 1,214,503 | $0.12 | $145,740 |
| 2026-07-17 | 3,524,381 | $0.15 | $528,657 |
| 2026-07-16 | 687,997 | $0.11 | $75,680 |
| 2026-07-10 | 60,524 | $0.12 | $7,263 |
| 2026-07-09 | 61,066 | $0.12 | $7,328 |
| 2026-07-08 | 1,280,802 | $0.13 | $166,504 |
| 2026-07-07 | 1,887,587 | $0.14 | $264,262 |
| 2026-07-06 | 4,995,376 | $0.14 | $699,353 |
| 2026-07-02 | 397,866 | $0.11 | $43,765 |
| 2026-07-01 | 367,494 | $0.11 | $40,424 |
| 2026-06-30 | 80,629 | $0.11 | $8,869 |
| 2026-06-22 | 127,828 | $0.12 | $15,339 |
| 2026-06-18 | 10,050 | $0.12 | $1,206 |
| 2026-06-15 | 38,812 | $0.12 | $4,657 |
| 2026-06-11 | 3,260 | $0.14 | $456 |
| 2026-06-10 | 10,496 | $0.13 | $1,364 |
| 2026-06-09 | 155,648 | $0.14 | $21,791 |
| 2026-06-04 | 249,453 | $0.15 | $37,418 |
| 2026-06-03 | 112,153 | $0.20 | $22,431 |
| 2026-06-01 | 42,514 | $0.16 | $6,802 |
Showing 1–29 of 29 settlements